Clorox Rises After FY2027 Sales Forecast Despite Modest Underlying Growth
The Clorox Company projected a 13% to 14% increase in sales for fiscal 2027. However, the majority of this recovery is attributed to acquisitions and timing-related factors.
Clorox Dips 0.4% as Lettuce Scare Seen Cutting U.S. Retail Sales by 0.55%
Shares of The Clorox Company edged down 0.37% to $105.55 on Tuesday. Hidden Valley Ranch sales have started to feel the effects of a lettuce-related illness outbreak. According to Nielsen data referenced by TD Cowen, sales dropped 5% over four weeks.
NYSE: CLX · Investor dashboard
Clorox: salad concerns and slim organic growth margin
As of 4:00 p.m. EDT on August 18, 2026, the U.S. market had closed, with market data reflecting this time.
Outbreak data checked Aug. 18, 2026
Close
$105.55
−0.37% Tuesday
Year to date+5.3%
52-week range$84.70–$128.90
Hidden Valley signal
−5%
Four-week dressing sales
Share of U.S. retail sales11%
Implied drag*−0.55%
Preliminary estimateFDA outbreak scope
9,481
Confirmed illnesses
Since August 5+49.1%
Hospitalizations398
States17
Company exposure: minor brand decline, greater projected impact
Budget structure
FY26 net-sales growth−5%
FY27 sales outlook+13% to +14%
FY27 organic outlook+3.5% to +4.5%
FY27 adjusted EPS$5.70–$6.00
GOJO contributes roughly 9.5 percentage points to the projected sales growth, while the ERP comparison adds over 3.5 points to organic growth.
Highlighted analyst targets following earnings
| Firm | View | Target | Vs. close |
|---|---|---|---|
| RBC Capital | Sector Perform | $110 | up 4.2% |
| UBS | Neutral | $105 | down 0.5% |
| Wells Fargo | Equal-Weight | $102 | off 3.4% |
| Evercore ISI | Underperform | $99 | lower by 6.2% |
| JPMorgan | Underweight | $95 | down 10.0% |
Selected targets published August 4, 2026. Five-target average: $102.20, or 3.2% below the August 18 close. *Implied drag equals 11% category exposure multiplied by a 5% sales decline; it is not company guidance. Sources: MarketWatch/TD Cowen/Nielsen, FDA, Clorox, FactSet and published broker notes.
Clorox (NYSE:CLX) Dividend Yield at 5.2% as U.S. Markets Shut, But Earnings Cushion Remains Slim
The Clorox Company ended Friday trading with an implied annualized yield of 5.15%, if the current $1.24 quarterly dividend is maintained. The earnings cushion remains slim.
Clorox (NYSE:CLX) 5.15% yield supported by modest earnings buffer
Clorox Company is now offering an annualized dividend of $4.96, which represents roughly 102% of its most recent GAAP outlook midpoint. Shares ended Friday at $96.32, putting the yield at 5.15%.
Clorox (NYSE:CLX) gains 3.8% in New York, but 5% yield gets tested as payout ratio runs at 89%
The Clorox Company rallied 3.75% Friday to close at $96.56, snapping back sharply to end the week. Still, the stock ended 0.7% under its July 2 price and just 44 cents below FactSet Research Systems’ $97 median analyst target.
Clorox Shares Gain 5% As Broader Market Drops—What’s Ahead
Clorox stock bounced Friday, bucking a sharp Wall Street selloff. The household-products maker caught a lift at the end of the week, coming off a rough patch after cutting guidance and swapping CEOs with little warning.
Clorox slips as CEO departure announced
Clorox shares finished the short week down hard after Chair and CEO Linda Rendle said she’s leaving for health reasons. The news put succession risk in the mix for a stock already dealing with slow sales growth and a cut profit outlook.
Clorox Stock Sinks After Outlook Cut: Why the Bleach Maker’s Profit Squeeze Isn’t Over
Clorox shares dropped 9.7% to $87.11 Friday, after the household-products company pared back its profit forecast for the year. The move is the latest blow for Clorox, which is still contending with elevated supply-chain expenses and lagging market-share gains in some segments.
Clorox Stock Slumps After Profit Forecast Cut as Purell Deal and Oil Costs Bite
Shares of The Clorox Company dropped roughly 9.6% to $87.11 Friday after the consumer products giant slashed its outlook for fiscal 2026 profit. The company blamed margin pressure on rising energy expenses, the timing of retail inventory, and additional costs linked to its Purell acquisition.
Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next
Procter & Gamble shares climbed 1.1% to $151.58 Friday afternoon, after fluctuating between $149.19 and $151.61. Roughly 5.2 million shares traded hands.
Clorox stock (CLX) ends week higher: what to watch on dividend, Glad shift, ERP fallout
Shares of The Clorox Company rose about 1.9% to $106.19 on Friday, their third straight gain, and beat smaller moves in Procter & Gamble and Colgate-Palmolive as U.S. stocks advanced. Volume was 1.9 million shares, below the stock’s 50-day average, and the close left Clorox about 35% under its 52-week high.
Palantir’s ‘Otherworldly’ Earnings & Wegovy Deal Buzz Spark After-Hours Stock Fireworks
Palantir Technologies delivered a record third quarter, easily topping analyst expectations on both revenue and profit. The company’s revenue jumped 63% year-over-year to $1.18 billion, with adjusted earnings of $0.21 per share – well above estimates of about $0.17investopedia.com. CEO Alex Karp credited booming demand for Palantir’s Artificial Intelligence Platform, especially among commercial customers. U.S. commercial revenue more than doubled to $397 million, outpacing even robust growth in government contractsinvestopedia.com. Karp hailed the commercial business as an “absolute juggernaut” and lauded the company’s “otherworldly” AI-driven growth in a letter to investorsinvestopedia.com.
TechStock² Updates
